Stay updated with breaking news from Mark Toshner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A drug used to reduce the risk of blood clots does not help patients recovering from moderate and severe COVID-19, despite this approach being offered to patients, a UK-wide trial, led by Addenbrooke's Hospital and the University of Cambridge has found.
The HEAL-COVID trial (Helping to Alleviate the Longer-term consequences of COVID-19) is funded by the National Institute for Health and Care Research (NIHR)
A recent investigation published by the British Medical Journal revealed that long COVID patients are traveling abroad to seek expensive blood-washing treatment. This experimental treatment the medical name for which is apheresis involves taking blood from the body and filtering it.
Much remains unknown about the condition, complicating the race to find treatment.
Long COVID: With One In Three Patients Back In Hospital After Three Months, Where Are The Treatments? Jul 21, 2021 01:04 AM By The Conversation The pace of acute therapy and vaccine development for COVID have been dizzying. But even as we hope a route to bringing the pandemic under control is within sight, we’re now facing the possibility of another urgent public health emergency thanks to what’s known as long COVID, a group of symptoms that last long after the initial infection. With such a potential crisis looming, it is reasonable to ask what we are doing about it, and why treat...